1201. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. In: Hansten PD, Horn JR. Drug interactions analysis and management. The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus. Kernan WN, Ovbiagele B, Black HR et al. Amlodipine better than lisinopril: how one randomized clinical trial ended fallacies from observational studies? Cifu AS, Davis AM. 143. Arsura EL, Scher DL. Patel A, ADVANCE Collaborative Group, MacMahon S et al. Rockville, MD: The United States Pharmacopeial Convention, Inc; 1995:11-2,524-6.238. Pool PE, Seagren SC, Salel AF et al.

14th ed. Dallas, TX; 1995 Aug 28.214. Henry M, Kay MM, Viccellio P. Cardiogenic shock associated with calcium-channel and beta blockers: reversal with intravenous calcium chloride. 224. Habib GB. 307. Clinical experience with diltiazem in Japan. Dustan HP. 243.

Diltiazem is an antihypertensive and vasodilating agent that works by … The role of calcium channel blockers in the treatment of hypertension. ... Pharmacodynamics. Hospira, Inc. Diltiazem hydrochloride powder for solution prescribing information. The United States pharmacopeia, 22nd rev, and The national formulary, 17th ed. Moser M, Lunn J, Materson BJ. Massie BM. 236. Whelton PK, Carey RM, Aronow WS et al. It may also be used in hyperthyroidism if beta blockers cannot be used. West Haven, CT; 1995 Mar 15. Falk RH. 183. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. 286. Höglund P, Nilsson LG. WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M et al. 313. Drug interaction facts. Advisory group reports on silent myocardial ischemia, coronary atherogenesis, and cardiac emergencies. 231. Calcium channel blockers and myocardial infarction: a hypothesis formulated but not yet tested. The influence of diltiazem hydrochloride on trough serum digoxin concentrations. Gershanik J, Boecler B, Ensley H et al.

Wolfson P, Abernethy D, DiPette DJ et al. 1216. 185. Mylan. Bethesda, MD: American Society of Hospital Pharmacists; 2018.b. 182. Menon PA, Thach BT, Smith CH et al. Pharmacokinetics of diltiazem and other calcium entry blockers. 330. 117. Diltiazem peak and systemic exposures were not affected by concurrent food intake.The apparent volume of distribution of diltiazem was approximately 305 L following a single intravenous injection in healthy male volunteers.Diltiazem is about 70-80% bound to plasma proteins, according to Diltiazem is subject to extensive first-pass metabolism, which explains its relatively low absolute oral bioavailability. Goldstein RE, Boccuzzi SJ, Cruess D et al. Morgantown, WV; 1997 Jan.HID. 148. Clinical events in high-risk hypertensive patients randomly assigned to calcium-channel blocker versus angiotensin-converting enzyme inhibitor in the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial. 329. Vancouver, WA: Applied Therapeutics, Inc; 1997: 141.128.

202. 269.

Rate-dependent effects of diltiazem on human atrioventricular nodal properties. Author information: (1)Department of Pharmaceutical Sciences, State University of New York at Buffalo, 14260, USA. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Carbamazepine neurotoxic reaction after administration of diltiazem. 504. When given by injection, effects typically begin within a few minutes and last a few hours. Weir MR, Josselson J, Giard MJ et al. Wright JT, Dunn JK, Cutler JA et al. Drug interaction facts. From FDA website. Sugihara J, Sugawara Y, Ando H et al. The USP Drug Nomenclature Committee. By continuing you agree to the Copyright © 2020 Elsevier B.V. or its licensors or contributors. Kiowski W, Bühler FR, Fadayomi MO et al. 1982; 2:156-61.116. 102. Cylosporine/diltiazem. Okada M, Inoue H, Nakamura Y et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Schrager BR, Pina I, Frangi M et al.